Predictors of improvement and progression of diabetic polyneuropathy following treatment with alpha-lipoic acid for 4 years in the NATHAN 1 trial Article

authors

publication date

  • March 1, 2016

webpage

published in

keywords

  • Autonomic function
  • Cardiovascular risk factors
  • Diabetic polyneuropathy
  • Neuropathic impairments
  • alpha-lipoic acid

start page

  • 350

end page

  • 356

volume

  • 30

issue

  • 2